ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

VERV Verve Therapeutics Inc

6.30
0.08 (1.29%)
15 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Verve Therapeutics Inc VERV 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.08 1.29% 6.30 09:00:00
개장가 저가 고가 종가 전일 종가
6.51 6.13 6.83 6.23 6.22
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/05/202420:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202420:15EDGAR2Form 8-K - Current report
08/05/202420:00GLOBEVerve Therapeutics Announces Pipeline Progress and Reports..
07/05/202420:00GLOBEVerve Therapeutics Announces Dosing of First Patient in..
04/05/202405:01GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
02/04/202420:00GLOBEVerve Therapeutics Announces Updates on its PCSK9 Program
29/03/202405:51GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
02/03/202406:01GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
27/02/202422:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/02/202422:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202421:45EDGAR2Form 8-K - Current report
27/02/202421:30GLOBEVerve Therapeutics Provides Pipeline Progress and Reports..
17/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202420:30GLOBEVerve Therapeutics to Participate in the Guggenheim..
02/01/202420:30GLOBEVerve Therapeutics to Present at the 42nd Annual J.P. Morgan..
02/12/202306:00GLOBEVerve Therapeutics Announces Closing of Public Offering of..
30/11/202306:54EDGAR2Form 8-K - Current report
30/11/202306:47EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/11/202320:47DJNVerve Therapeutics Shares Tumble Premarket After Stock Sales
29/11/202312:37GLOBEVerve Therapeutics Announces Pricing of Public Offering of..
29/11/202306:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/11/202306:01GLOBEVerve Therapeutics Announces Proposed Public Offering of..
13/11/202320:34EDGAR2Form 8-K - Current report
13/11/202305:30GLOBEVerve Therapeutics Announces Interim Data for VERVE-101..
07/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:00EDGAR2Form 8-K - Current report
07/11/202320:30GLOBEVerve Therapeutics Highlights Recent Company Progress and..
31/10/202319:59DJNBeam Therapeutics to Sell Rights in Verve Licensing Deal to..
31/10/202319:01GLOBEVerve and Lilly Relationship Expands to Include Verve’s In..
23/10/202320:22DJNVerve Therapeutics Gets Clinical Hold For VERVE-101 Lifted..
23/10/202319:41EDGAR2Form 8-K - Current report
23/10/202319:30GLOBEVerve Therapeutics Announces Clearance of Investigational..
26/09/202319:30GLOBEVerve to Present Interim Data from the heart-1 Phase 1b..
22/09/202305:05GLOBEVerve Therapeutics to Participate in the 2023 Cantor Global..
18/09/202319:30GLOBEVerve Expands Leadership Team with Appointment of Frederick..
10/08/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:00EDGAR2Form 8-K - Current report
10/08/202319:30GLOBEVerve Therapeutics Highlights Recent Company Progress and..
03/08/202319:30GLOBEVerve Therapeutics to Present at the Canaccord 43rd Annual..
15/06/202320:16DJNVerve Therapeutics Strikes Gene Editing Deal With Eli Lilly
15/06/202319:30GLOBEVerve Establishes Global Collaboration with Lilly to Advance..
01/06/202319:30GLOBEVerve Therapeutics to Participate in the 2023 Jefferies..
23/05/202319:30GLOBEVerve Therapeutics to Participate in the Stifel 2023..

최근 히스토리

Delayed Upgrade Clock